NYC Official Who Mocked Charlie Kirk's Death Is In Deep Trouble
You Won't Believe What Don Lemon Thinks of Those Upset About That Anti-ICE...
Anti-Gunner Hacks Use Martin Luther King Jr. to Push for Gun Control, but...
Bishop Barron's Bully Pulpit
Illinois’ Answer to Career Criminals: Seal Their Records
Don Lemon Leads Activist Mob, Quickly Regrets It; Margaret Brennan's Fact-Free Dispute Wit...
UNC–Chapel Hill Awarded Major Federal Grant to Expand Civic Education
A New Lawsuit Alleges Eric Swalwell Cannot Run for California Governor. Here's Why.
The Party of Science Debuts a Bold New Theory About Menopause
The Week Deportations Stayed Strong—and Backing Off Would Be a GOP Disaster
16,500 Dead and 330,000 Injured As Iran’s Brutal Crackdown Brings Protests to a...
ADL Targets Tucker Carlson Ss It Teams With GOP Lawmakers to Fight Antisemitism
DOJ to Investigate and Arrest Don Lemon and Minneapolis Church Stormers
DHS Just Announced Huge Arrest Numbers in Minnesota
Texas School District to Host 'Islamic Games'
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos